Gsk (GSK) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Gsk (GSK) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.26 Bn | 602.28 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 362.26 Bn | 362.26 Bn | - | - |
| 3 | General Electric | 329.74 Bn | 320.40 Bn | 6.95 Bn | 2.45% |
| 4 | Astrazeneca | 254.36 Bn | 249.07 Bn | 12.86 Bn | -15.78% |
| 5 | Citigroup | 228.02 Bn | -2,074.28 Bn | 24.75 Bn | - |
| 6 | Bhp | 215.87 Bn | 197.32 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.49 Bn | 195.46 Bn | - | - |
| 9 | Unilever | 139.16 Bn | 132.13 Bn | - | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.86% |
| Mar 31, 2026 | -13.73% |
| Dec 31, 2025 | -7.97% |
| Sep 30, 2025 | -5.90% |
| Jun 30, 2025 | 10.41% |
| Mar 31, 2025 | 16.73% |
| Dec 31, 2024 | -7.52% |
| Sep 30, 2024 | -4.63% |
| Jun 30, 2024 | -2.91% |
| Mar 31, 2024 | -11.08% |
| Dec 31, 2023 | 51.03% |
| Sep 30, 2023 | -16.86% |
| Jun 30, 2023 | -24.11% |
| Mar 31, 2023 | -9.36% |
| Dec 31, 2022 | -4.69% |
| Sep 30, 2022 | 15.74% |
| Jun 30, 2022 | 10.66% |
| Mar 31, 2022 | 6.56% |
| Dec 31, 2021 | 20.89% |
| Sep 30, 2021 | 27.67% |